Open AccessIntracardiac Thrombus Revealing Coronavirus Disease 2019 (COVID-19). About a Case, Renaissance University Hospital Center in N’Djamena (Chad)
Author(s) -
Adam Ahamat Ali,
AUTHOR_ID
Publication year - 2020
Publication title -
series of cardiology research
Language(s) - English
Resource type - Journals
ISSN - 2768-5985
DOI - 10.54178/2768-5985.2020a4
Subject(s) - medicine , thrombus , covid-19 , cardiology , azithromycin , coronavirus , hydroxychloroquine , disease , infectious disease (medical specialty) , microbiology and biotechnology , biology , antibiotics
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) called COVID-19 is often associated with thrombotic complications, especially in severe cases. We report a case of COVID-19 revealed by a right intraatrial thrombus to emphasize the risk of thromboembolic diseases linked to this pathology. He was a young subject, 41 years old, with no notable history. He complained of asthenia and precordialgia. Echocardiography showed the presence of a right intraatrial thrombus and laboratory tests confirmed COVID-19. Under medical treatment combining antithrombotics, chloroquine and azithromycin, the thrombus regressed, and the markers of inflammation were normalized after 12 days. One month later, the patient remained clinically stable with normal echocardiography.